wsp vaccine
Vaccineexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 29, 2025 (NCT07216430)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- PlasmodiumImmunity, active
Plasmodium immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07216430 | Phase 2 | Sep 29, 2025 | Alira Health, National Institute of Allergy and Infectious Diseases (NIAID), Serum Institute of India Pvt. Ltd., Serum Life Science Europe GmbH, University of Rochester |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Alira Health | Academic/Hospital | 1 | 0 | 1 | 2025 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 0 | 1 | 2025 |
| Serum Institute of India Pvt. Ltd. | For profit | 1 | 0 | 1 | 2025 |
| Serum Life Science Europe GmbH | For profit | 1 | 1 | 1 | 2025 |
| University of Rochester | Academic/Hospital | 1 | 0 | 1 | 2025 |
5 organizations
Page 1 / 1